Anti-CA2D1/ CACNA2D1/ CACNA2 functional antibody

Anti-CA2D1/ CACNA2D1/ CACNA2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CACNA2D1/CACNA2D1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T84316-Ab-1/ GM-Tg-hg-T84316-Ab-2Anti-Human CACNA2D1 monoclonal antibodyHuman
GM-Tg-rg-T84316-Ab-1/ GM-Tg-rg-T84316-Ab-2Anti-Rat CACNA2D1 monoclonal antibodyRat
GM-Tg-mg-T84316-Ab-1/ GM-Tg-mg-T84316-Ab-2Anti-Mouse CACNA2D1 monoclonal antibodyMouse
GM-Tg-cynog-T84316-Ab-1/ GM-Tg-cynog-T84316-Ab-2Anti-Cynomolgus/ Rhesus macaque CACNA2D1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T84316-Ab-1/ GM-Tg-felg-T84316-Ab-2Anti-Feline CACNA2D1 monoclonal antibodyFeline
GM-Tg-cang-T84316-Ab-1/ GM-Tg-cang-T84316-Ab-2Anti-Canine CACNA2D1 monoclonal antibodyCanine
GM-Tg-bovg-T84316-Ab-1/ GM-Tg-bovg-T84316-Ab-2Anti-Bovine CACNA2D1 monoclonal antibodyBovine
GM-Tg-equg-T84316-Ab-1/ GM-Tg-equg-T84316-Ab-2Anti-Equine CACNA2D1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T84316-Ab-1/ GM-Tg-hg-T84316-Ab-2; GM-Tg-rg-T84316-Ab-1/ GM-Tg-rg-T84316-Ab-2;
GM-Tg-mg-T84316-Ab-1/ GM-Tg-mg-T84316-Ab-2; GM-Tg-cynog-T84316-Ab-1/ GM-Tg-cynog-T84316-Ab-2;
GM-Tg-felg-T84316-Ab-1/ GM-Tg-felg-T84316-Ab-2; GM-Tg-cang-T84316-Ab-1/ GM-Tg-cang-T84316-Ab-2;
GM-Tg-bovg-T84316-Ab-1/ GM-Tg-bovg-T84316-Ab-2; GM-Tg-equg-T84316-Ab-1/ GM-Tg-equg-T84316-Ab-2
Products NameAnti-CACNA2D1 monoclonal antibody
Formatmab
Target NameCACNA2D1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CACNA2D1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T84316-Ag-1Recombinant multi-species CA2D1/ CACNA2D1/ CACNA2 protein


    Target information

    Target IDGM-T84316
    Target NameCACNA2D1
    Gene ID781,12293,25399,708215,610342,101099450,282608,100057533
    Gene Symbol and SynonymsCa(v)alpha2delta1,CACNA2,CACNA2D1,CACNL2A,CCHL2A,CCHLA2,DEE110,DHSCCA,LINC01112,lncRNA-N3
    Uniprot AccessionP54289,P54290
    Uniprot Entry NameCA2D1_HUMAN,CA2D1_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000153956
    Target ClassificationN/A

    The target: CACNA2D1, gene name: CACNA2D1, also named as CACNA2, CACNL2A, CCHL2A, LINC01112, lncRNA-N3. The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.